InSightec ExAblate 2000 Approved For Uterine Fibroids; 3-Year Study Required

FDA approval conditions for InSightec's ExAblate 2000 uterine fibroid ultrasound treatment respond to advisory panel concerns about short-term safety and efficacy data in the original PMA submission

More from Archive

More from Medtech Insight